癌症病毒免疫疗法平台基于疹病毒和细胞巨乳病毒
Haifei Jiang1, Kah Whye Peng1, Stephen J Russell2
1Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA.
概括
使用简单疹病毒 (HSV) 的瘤性病毒疗法显示出希望,但面临局限性. 疹病毒 (VZV) 和细胞巨乳病毒 (CMV) 通过利用对瘤的免疫反应,为癌症治疗提供了新的潜力.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 免疫治疗是一种免疫疗法.
背景情况:
- 基于简单疹病毒 (HSV) 的结性病毒疗法已经显示出对各种癌症的有效性.
- 目前的HSV应用有限,这给更广泛的癌症治疗带来了挑战.
- 新兴的疹病毒,疹病毒 (VZV) 和细胞巨血病毒 (CMV) 正在被探索为瘤性病毒疗法.
研究的目的:
- 审查VZV和CMV在型病毒治疗中的潜力.
- 探索由VZV和CMV激活的T细胞和自然杀手 (NK) 细胞对瘤的交叉反应.
- 总结VZV和CMV载体开发用于癌症免疫治疗的进展.
主要方法:
- 对VZV和CMV免疫反应的临床观察和实验发现的综述.
- 对型VZV和CMV的病毒工程,生产和传递策略的分析.
- 评估重定向病毒驱动免疫反应以控制瘤的可行性.
主要成果:
- VZV和CMV可以激活和放大T细胞和NK细胞的反应,具有潜在的瘤交叉反应性.
- 临床和实验数据支持使用VZV和CMV来利用抗瘤免疫力.
- 在工程,生产和交付oncolytic VZV和CMV载体方面取得了进展.
结论:
- VZV和CMV代表了开发新型癌症病毒免疫治疗的有希望的平台.
- 利用病毒驱动的免疫反应为有效的瘤控制提供了一种战略.
- 在建立基于VZV和CMV的强大的癌症病毒免疫疗法平台方面,仍然存在关键挑战.
相关概念视频
Cancer Vaccines
960
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
960
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Mechanisms of Retrovirus-induced Cancers
6.9K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.9K
Rous Sarcoma Virus (RSV) and Cancer
6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.2K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


